FilingReader Intelligence
Tecon Biology reports strong 2024, plans profit distribution
April 29, 2025 at 05:01 AM UTC•By FilingReader AI
Tecon Biology (SZSE:002100) announced its 2024 financial results, showcasing a year of improved profitability and strategic advancements. While revenue slightly decreased to CNY 17.18 billion, compared to CNY 19.03 billion in 2023, the company witnessed a surge in net profit attributable to shareholders, reaching CNY 605.05 million, a significant turnaround from a CNY 1.36 billion loss the previous year.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
2024 Annual Report of the Board of DirectorsApril 28, 2025 at 11:29 AM UTC
Announcement on the 2024 Profit Distribution PlanApril 28, 2025 at 11:29 AM UTC
Annual special audit report on related party funds misappropriationApril 28, 2025 at 11:29 AM UTC
2024 Annual Report SummaryApril 28, 2025 at 11:29 AM UTC
2024 Annual ReportApril 28, 2025 at 11:29 AM UTC
2024 Annual Audit ReportApril 28, 2025 at 11:29 AM UTC
Internal Control Audit ReportApril 28, 2025 at 11:29 AM UTC
Announcement on Changes in Accounting PoliciesApril 28, 2025 at 11:29 AM UTC
Goodwill impairment test reportApril 28, 2025 at 11:29 AM UTC
Annual report on the use of raised fundsApril 28, 2025 at 11:29 AM UTC
2025 Financial Budget ReportApril 28, 2025 at 11:29 AM UTC
Announcement on the Provision for Inventory Impairment in 2024April 28, 2025 at 11:29 AM UTC
News Alerts
Get instant email alerts when Tecon Biology publishes news
Free account required • Unsubscribe anytime